Fulcrum Therapeutics, Inc. - COM (FULC)

Historical Portfolio Holders from Q3 2019 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
59.2 M
Holdings value Q1 2024
$559 M
Value change Q1 2024
-$2.41 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
119
Number of buys Q1 2024
66
Number of sells Q1 2024
-39
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.001%
CUSIP
359616109
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 59.2 M $559 M -$2.41 M $9.44 119
2023 Q4 59.9 M $404 M +$12.1 M $6.75 99
2023 Q3 56.4 M $250 M +$9.2 M $4.44 80
2023 Q2 55.5 M $183 M -$14.2 M $3.30 85
2023 Q1 60.4 M $172 M -$2.27 M $2.85 116
2022 Q4 49.2 M $359 M -$5.89 M $7.28 107
2022 Q3 48.3 M $391 M +$99.4 M $8.09 96
2022 Q2 33.9 M $166 M -$29.8 M $4.90 96
2022 Q1 39.1 M $924 M +$64.9 M $23.65 102
2021 Q4 36.8 M $651 M -$42.9 M $17.69 105
2021 Q3 35 M $987 M +$297 M $28.21 99
2021 Q2 25.4 M $266 M -$7.53 M $10.48 64
2021 Q1 23.6 M $278 M +$37.7 M $11.78 66
2020 Q4 22.2 M $260 M +$20.2 M $11.71 65
2020 Q3 20 M $158 M -$38.3 M $7.93 52
2020 Q2 20.5 M $374 M +$66.4 M $18.29 59
2020 Q1 16.8 M $201 M +$11.9 M $11.94 46
2019 Q4 15.8 M $262 M +$1.41 M $16.64 37
2019 Q3 15.9 M $105 M +$89.5 M $6.64 35